Semax + Selank
Peptide Stack · Combination ConceptCognitive, attention, and stress-modulation research
What Is This Combination?
ERP catalog context: Semax 10 mg + Selank 10 mg -- total 20 mg
A pairing of Semax's cognitive/attention research framing with Selank's anxiolytic/stress-modulation research framing -- a community-described pairing of complementary research themes, not a demonstrated pharmacodynamic correction of one by the other.
The Concept
Community framing often casts Semax toward cognitive/attention/neurotrophic research and Selank toward anxiolytic/stress-modulation research. The combined idea is often described as pairing cognition or focus with calmer stress signaling. Selank does not "balance" Semax as a demonstrated pharmacodynamic fact -- that is a community framing, not an established finding.
Meet the Components
Semax
10 mgcognitive/attention/neurotrophic-signaling research arm
Semax is studied in the research literature in relation to cognition, attention, and neurotrophic signaling.
Evidence base is relatively small and internationally uneven, with limited modern replication. See the standalone Semax page for its full evidence summary.
Limited, uneven evidence base
View Semaxresearch profile →Selank
10 mganxiolytic/stress-modulation signaling research arm
Selank is studied in the research literature in relation to anxiolytic and stress-modulation signaling, a distinct research arm from Semax's cognitive/attention framing.
Evidence base is relatively small and internationally uneven, with limited modern replication. See the standalone Selank page for its full evidence summary.
Limited, uneven evidence base
View Selankresearch profile →How the Roles Fit Together
What the Combination Is Intended to Address
Evidence-Supported Conceptual Domains
- cognition
- attention/focus research
- stress/anxiety-related signaling
- neurobehavioral research
Community-Use Themes
The themes below are editorial summaries of commonly discussed community-use patterns. They are not controlled clinical evidence, systematically sourced community data, or established benefits.
- focus with less perceived anxiety(editorial-summary)
- motivation and productivity discussions(editorial-summary)
- mental clarity discussions(editorial-summary)
- stress resilience discussions(editorial-summary)
Concerns & Evidence Gaps
Safety Consideration
No robust exact-combination efficacy evidence exists.Safety Consideration
Each component's own individual evidence base is relatively small and internationally uneven, with limited modern replication.Safety Consideration
Long-term combination safety is unclear.Safety Consideration
Mood, headache, agitation, sedation, and nasal-irritation attribution becomes harder to sort out when both compounds are introduced together.Safety Consideration
No validated mass ratio has been established for this combination.
Why Separate Components May Sometimes Be Preferable
Presented as a scientific/practical tradeoff, not a recommendation.
Favoring Separate Administration
- Separate administration allows clean attribution of any cognitive or mood effect to a specific component.
- The two compounds may have different potential timing or effect profiles that are easier to observe individually.
- Each component's own limited, uneven evidence base is easier to reason about without a second, differently-studied compound layered on top.
- Independent administration allows either component to be held or stopped without discontinuing the other.
Favoring the Fixed-Ratio Blend
- A single combined vial is more convenient to source and administer than two separate components on two schedules.
Convenience is not evidence of biological superiority.
Evidence Boundary
The components of this combination have been investigated individually to varying degrees. Evidence for an individual component does not automatically establish the safety, efficacy, compatibility, or synergy of the exact combination. Where direct combination studies exist, MitoCore identifies that explicitly. Where they do not, the page describes the biological rationale for the combination rather than presenting the stack itself as a validated therapeutic intervention.
Exact-combination status: No robust exact-combination efficacy evidence for Semax plus Selank was located. Each component's own individual evidence base is relatively small and internationally uneven, with limited modern replication, and neither component's literature establishes anything about the combination.
Limitations: Community descriptions of Selank "balancing" Semax are a framing, not a demonstrated pharmacodynamic interaction. No controlled trial of the combination, and no evidence-derived mass ratio, has been established.
Component evidence: Both components carry relatively small, internationally uneven individual evidence bases -- see each component's own standalone page for its full evidence summary.
Explore the Components
Each component's full evidence base lives on its own standalone research profile.
Semax
Semax is a synthetic peptide-based compound often discussed for focus, cognition, and neuroprotective mechanisms. It has more regional history of use than many gray-market peptides, but U.S.-style FDA-approved indications for common nootropic claims are lacking. This page summarizes Semax's regulatory status, small/limited human evidence, preclinical findings, and anecdotal nootropic reports.
View research profile →Selank
Selank is a synthetic peptide-based compound often discussed for stress response, anxiety, and neuroprotective mechanisms. It has more regional history of use than many gray-market peptides, but U.S.-style FDA-approved indications for common anxiolytic claims are lacking. This page summarizes Selank's regulatory status, small/limited human evidence, preclinical findings, and anecdotal nootropic reports.
View research profile →Disclaimer
See the anecdotal notice above for community-discussion context.
This page does not establish combination efficacy, safety, or compatibility beyond what is explicitly cited above. Always review each component's own standalone research profile for its full evidence base.